EXACT Sciences Corporation


Stock Update (NASDAQ:EXAS): EXACT Sciences Corporation Names John Bakewell Chief Financial Officer

EXACT Sciences Corporation (NASDAQ:EXAS) announced the appointment of John K. Bakewell as chief financial officer.

Company Update (NASDAQ:EXAS): CMS Corrects 2016 Reimbursement Rate for EXACT Sciences Corporation’s Cologuard

EXACT Sciences Corporation (NASDAQ:EXAS) announced that the Centers for Medicare and Medicaid Services (CMS) indicated that it is correcting the 2016 Clinical Laboratory Fee …

Stock Update (NASDAQ:EXAS): Exact Sciences Corporation’s Stool DNA Screening Technology to be Featured at ACG 2015

Exact Sciences Corporation (NASDAQ:EXAS) announced that data supporting its stool DNA (sDNA) screening platform for colorectal cancer will be presented in three posters at the …

Canaccord Slashes Price Target For Exact Sciences Corporation (EXAS) As Risk/Reward Looks Less Compelling

In a research report issued Wednesday, Canaccord analyst Mark Massaro reiterated a Buy rating on shares of Exact Sciences Corporation (NASDAQ:EXAS), while reducing the …

Wednesday’s Market Insights: Seadrill Ltd (SDRL), GoPro Inc (GPRO), Tesla Motors Inc (TSLA), EXACT Sciences Corporation (EXAS)

Seadrill Ltd (NYSE:SDRL) is up more than 6% in pre-market trading to $7.75 as oil prices continue to rally thanks to a recent …

We See Exact Sciences Corporation (EXAS) Sell-off as Overdone: Roth Capital

In a research report released today, Roth Capital analyst Chris Lewis reiterated a Buy rating on shares of Exact Sciences Corporation (NASDAQ:EXAS), while reducing …

Analysts Weigh in on Two Collapsing Biotechs: Illumina, Inc. (ILMN), EXACT Sciences Corporation (EXAS)

Analysts are weighing in on the gene-sequencing company Illumina, Inc. (NASDAQ:ILMN) and molecular diagnostics company EXACT Sciences Corporation (NASDAQ:EXAS), as shares of both companies are trading …

Stock Update (NASDAQ:EXAS): EXACT Sciences Corporation’s Cologuard Included as Alternative Screening Test under Draft USPSTF Guidelines

EXACT Sciences Corporation (NASDAQ:EXAS) issued the following statement today following the U.S.

Company Update (NASDAQ:EXAS): CMS Issues Preliminary Determination Maintaining EXACT Sciences Corporation Cologuard® Reimbursement Rate

EXACT Sciences Corporation (NASDAQ:EXAS) announced that the Centers for Medicare and Medicaid Services(CMS) issued a preliminary determination maintaining the current reimbursement rate for Cologuard, …

Canaccord Pounds the Table on EXACT Sciences Corporation (EXAS)

Canaccord analyst Mark Massaro was out pounding the table on EXACT Sciences Corporation (NASDAQ:EXAS) Thursday, reiterating a Buy rating and price target of $26, …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts